tiprankstipranks
Advertisement
Advertisement
Oncolys BioPharma Reports 2024 Financial Results Highlighting Improved Equity Ratio
PremiumCompany AnnouncementsOncolys BioPharma Reports 2024 Financial Results Highlighting Improved Equity Ratio
1y ago
Oncolys BioPharma’s Telomelysin Shows Promising Results in Phase I Trial
Premium
Company Announcements
Oncolys BioPharma’s Telomelysin Shows Promising Results in Phase I Trial
1y ago
Oncolys BioPharma Reports Decline in Sales Amidst Uncertainty
Premium
Company Announcements
Oncolys BioPharma Reports Decline in Sales Amidst Uncertainty
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100